Sorrento Therapeutics Buys Concortis Biosystems
socalTECH
NOVEMBER 14, 2013
San Diego-based Sorrento Therapeutics announced this morning that it is acquiring fellow, San Diego biotech Concortis Biosystems , to bolster its library of antibodies. The deal is worth approximately $11.6M, based on the recent pricing of Sorrento''s stock. READ MORE>>.
Let's personalize your content